ALLG Monitors COVID-19 Situation Across ANZ

Posted 13/03/2020

The ALLG is continuing to monitor the coronavirus (COVID-19) situation closely.

As a provider of clinical trials and research services for patients with blood cancers, the ALLG is a wide-reaching organisation with over 880 members at 92 hospitals and cancer centres across Australia and New Zealand. The wellbeing of our members, most of whom are healthcare workers, and the patients participating in ALLG clinical trials is our top priority.

We want to ensure that our members, staff and clinical trial participants have the latest information and encourage those involved in ALLG clinical trials to keep up-to-date with the latest information from Australia and New Zealand (including states/territories) and remain vigilant with recommended preventative measures as per the advice of the national, state and local health authorities that relate to you.

As you read this issue of ALLG News, please note that the links and therefore advice on the pages connected to the links provided by the various authorities may be superceded as newer information becomes.

We will provide regular future updates.